Pharma job security issues
February 13, 2012
FOURTY-four percent of
pharmaceutical and biotech
company employees fear they will
be made redundant in the next 12
months, according to a new survey
by Pharma IQ.
The survey looked at responses
from 535 members of the
pharmaceutical community during
November and December 2011,
and found that a massive 71% of
participants think that Pharma is
undergoing a dramatic change due
to the current economic climate.
According to participants, the US
and Europe are the regions being hit
the worst by the climate, whilst only
7.3% identified Asia as the region
that was suffering the greatest in
the current financial climate.
Participants also identified the
R&D- preclinical sector as the area
of the pharmaceutical industry
which they felt the global economic
crisis had impacted the most (40%),
followed by sales and marketing
(30.7%), manufacturing (11.2%),
clinical (10.8%) regulatory affairs
(3.6%), IT (3.2%) and distribution (2.6%).
Looking towards the future, the
majority of participants did not
expect their budget to grow in
2012, however the majority do
expect that their department’s
budget will actually decrease
(40.7%) or stay the same (40.2%).
Interestingly, 47.5% of
respondents also told researchers
that they do not think that the
industry is well prepared for
another recession.
The above article was sent to subscribers in Pharmacy Daily's issue from 13 Feb 12To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 Feb 12
